Clinical Trials

BreastGastrointestinalGenitourinaryGynecologicOther solid neoplasmThoracic

200 enrolled

Mesothelioma, Malignant, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Kidney Neoplasms, Mesothelioma, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Colorectal Neoplasms, Triple Negative Breast Neoplasms

NCT05520099 2025-12-26

ELEPHAS-02

DermatologicGastrointestinalGenitourinaryGynecologicHead & NeckThoracic

416 enrolled

Squamous Cell Carcinoma of Head and Neck, Urinary Bladder Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Head and Neck Neoplasms, Carcinoma, Hepatocellular, Kidney Neoplasms, Liver Neoplasms, Lung Neoplasms, Melanoma, Neoplasms, Skin Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms

NCT04941768 2025-11-28

An Observational Study to Evaluate the Efficacy and Safety of Avelumab + Axitinib Combination in Participants With aRCC (AVION)

105 enrolled 11 charts

BreastDermatologicGenitourinaryHead & NeckThoracic

Carcinoma, Renal Cell

NCT07246759 2025-11-24

NEUTROFLOW

Not yet recruiting

600 enrolled

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Melanoma, Triple Negative Breast Neoplasms

NCT07024680 2025-11-18

PRCC

150 enrolled

Carcinoma, Renal Cell

NCT03374267 2025-09-22

CARAT

1,930 enrolled

Carcinoma, Renal Cell, Carcinoma, Transitional Cell

NCT05461430 2025-09-15

TraveraRTGx

BreastDermatologicEndocrineGastrointestinalGenitourinaryGynecologicHead & NeckOther solid neoplasmSarcomaThoracic

200 enrolled

Anus Neoplasms, Appendiceal Neoplasms, Ascites, Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Uterine Cervical Neoplasms, Colonic Neoplasms, Esophageal Neoplasms, Carcinoma, Hepatocellular, Laryngeal Neoplasms, Lung Neoplasms, Melanoma, Mesothelioma, Mouth Neoplasms, Nasopharyngeal Neoplasms, Neoplasms, Unknown Primary, Oropharyngeal Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Penile Neoplasms, Stomach Neoplasms, Thymoma, Vulvar Neoplasms, Pleural Effusion, Malignant, Carcinoma, Neuroendocrine, Cholangiocarcinoma, Carcinoma, Small Cell, Carcinoma, Pancreatic Ductal, Gastrointestinal Stromal Tumors

NCT05059444 2025-08-22

ORACLE

DermatologicGastrointestinalGenitourinaryGynecologicHead & NeckThoracic

2,020 enrolled

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Ovarian Epithelial, Urinary Bladder Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Esophageal Neoplasms, Fallopian Tube Neoplasms, Melanoma, Rectal Neoplasms, Ureteral Neoplasms, Endometrial Neoplasms

NCT06885424 2025-07-15

DESCENT-1

Enrolling by invitation

400 enrolled

BreastGastrointestinalGenitourinaryGynecologicHead & NeckOther solid neoplasmThoracic

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Head and Neck Neoplasms, Kidney Neoplasms, Mesothelioma, Ovarian Neoplasms, Pancreatic Neoplasms, Colorectal Neoplasms, Small Cell Lung Carcinoma, Triple Negative Breast Neoplasms

NCT02940639 2025-07-11

Real-Life Effectiveness and Safety in Participants With Advanced/Metastatic Renal Cell Carcinoma Starting 1st Line Nivolumab and Ipilimumab Combination Therapy or Nivolumab Monotherapy After Prior Therapy

499 enrolled

Carcinoma, Renal Cell

NCT03455452 2025-06-25

WITNESS

Active not recruiting

600 enrolled

Carcinoma, Renal Cell, Kidney Neoplasms

NCT04006405 2025-06-15

AUR87A

280 enrolled

Carcinoma, Renal Cell

NCT04804813 2025-04-11

Survey of Cabozantinib Used To Treat People With Renal Cell Carcinoma

388 enrolled 20 charts

Carcinoma, Renal Cell

NCT04043975 2025-02-14

A Study of Nivolumab Plus Ipilimumab in Participants With Renal Cell Cancer in the Real World Setting in Japan

286 enrolled

Carcinoma, Renal Cell

NCT05534789 2025-01-20

Treatment Patterns and Clinical Outcomes Among Patients With Advanced Renal Cell Carcinoma (aRCC) Receiving Systemic First-line (1st Line) Anti-cancer Treatment Under Daily Routine in Germany: Retrospective Medical Chart Review (RENALISTIC Study).

Terminated

106 enrolled 21 charts

Carcinoma, Renal Cell

NCT04985357 2024-11-25

Defining the Clinical Potential of Mass Response As a Biomarker for Patient Tumor Sensitivity to Drugs

BreastEndocrineGastrointestinalGenitourinaryGynecologicHead & NeckOther solid neoplasmThoracic

Anus Neoplasms, Appendiceal Neoplasms, Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Uterine Cervical Neoplasms, Esophageal Neoplasms, Carcinoma, Hepatocellular, Laryngeal Neoplasms, Lip Neoplasms, Lung Neoplasms, Mesothelioma, Mouth Neoplasms, Neoplasms, Unknown Primary, Oropharyngeal Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Paranasal Sinus Neoplasms, Penile Neoplasms, Prostatic Neoplasms, Thymoma, Vulvar Neoplasms, Pleural Effusion, Malignant, Carcinoma, Neuroendocrine, Cholangiocarcinoma, Carcinoma, Ductal, Small Cell Lung Carcinoma

NCT05363072 2024-10-01

A Study to Describe the Kidney Cancer Patient Population Treatment, and Results in the Hospital District of Southwest Finland.

1,112 enrolled 16 charts

Carcinoma, Renal Cell, Kidney Neoplasms

NCT01210482 2024-09-25

Temsirolimus (Torisel) Drug Use Investigation (Regulatory Post Marketing Commitment Plan)

1,050 enrolled 9 charts

Carcinoma, Renal Cell

NCT04375150 2024-09-19

Master Protocol to Study Treatment Patterns, Medication Adherence, Health and Economic Outcomes and Unmet Needs in RCC

355 enrolled 23 charts

Carcinoma, Renal Cell

NCT05745142 2024-08-05

A Study to go Back Into Records and Observe How People With Metastatic Renal Cell Carcinoma (mRCC) Who Received a Medicine Called Sunitinib Responded to This Medicine.

376 enrolled 17 charts

Clear-cell metastatic renal cell carcinoma, Carcinoma, Renal Cell

NCT03776123 2024-05-29

Post-marketing Surveillance on the Safety of CabometyxTM in Korean Patients

GastrointestinalGenitourinary

347 enrolled

Carcinoma, Renal Cell, Carcinoma, Hepatocellular

NCT03140176 2024-05-10

OPTIMISE

Terminated

77 enrolled 34 charts

Carcinoma, Renal Cell

NCT01117779 2024-01-19

TRACE

Terminated

246 enrolled 18 charts

Carcinoma, Renal Cell, Kidney Neoplasms

NCT05012865 2023-12-06

Current Treatment Outcomes in Japanese RCC Patients Treated With Avelumab Plus Axitinib as First-line Therapy: Retrospective Study (J-DART)

48 enrolled 36 charts

Carcinoma, Renal Cell

NCT04555603 2023-11-21

Axitinib Therapy Management Study

Carcinoma, Renal Cell

NCT06093568 2023-10-23

Delving Into Participation Trends in Renal Cell Carcinoma Studies

Not yet recruiting

500 enrolled

Carcinoma, Renal Cell

NCT00716625 2023-05-03

Special Investigation For Renal Cell Carcinoma (RCC) Of Sunitinib Malate (Regulatory Post Marketing Commitment Plan)

1,674 enrolled 17 charts

Carcinoma, Renal Cell

NCT04175262 2023-05-03

Clinical Outcomes For Patients With Metastatic Renal Cell Carcinoma (mRCC) Who Received Sunitinib After 1st Line Immune-oncology (IO) Treatments

102 enrolled 23 charts

Carcinoma, Renal Cell

NCT04076787 2023-04-06

Clinical Outcomes for Patients With Renal Cell Carcinoma Who Received First-Line Sunitinib

1,769 enrolled 12 charts

Carcinoma, Renal Cell

NCT02776644 2023-03-16

Clinical Outcome Of Advanced Renal Cell Carcinoma In Taiwan

1,349 enrolled 24 charts

Carcinoma, Renal Cell

NCT03419572 2022-08-15

CASSIOPE

689 enrolled

Carcinoma, Renal Cell

NCT04115189 2022-05-10

A Retrospective Medical Record Review of First-Line Sunitinib Administration Schedules and Outcomes Among Patients With mRCC in Latin America (LA)

57 enrolled 35 charts

Carcinoma, Renal Cell

NCT05037825 2022-04-27

PARADIGM

BreastDermatologicGenitourinaryThoracic

800 enrolled

Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Melanoma, Triple Negative Breast Neoplasms

NCT03663946 2022-02-25

A Study to Observe the Onset of Immune-related Adverse Reactions in Patients With Non-surgical or Renal Cell Carcinoma (RCC) That Has Spread

81 enrolled

BreastDermatologicGastrointestinalGenitourinaryGynecologicThoracic

Carcinoma, Renal Cell, Kidney Neoplasms

NCT05230186 2022-02-09

A Tissue Collection Study in Patients Who Respond to Immune Checkpoint Inhibitors to Identify Targets of Tumor-Reactive T Cells.

Unknown

200 enrolled

Urinary Bladder Neoplasms, Carcinoma, Renal Cell, Colonic Neoplasms, Lung Neoplasms, Melanoma, Endometrial Neoplasms, Triple Negative Breast Neoplasms

NCT05168436 2021-12-23

A Study of Preferences of Participants and Oncologists for the Characteristics of the Treatment for Renal Cell Carcinoma (RCC) In Spain And Portugal

105 enrolled

Carcinoma, Renal Cell

NCT03916458 2021-12-13

ATILA

62 enrolled 30 charts

Carcinoma, Renal Cell

NCT02789137 2021-11-05

TROYA

111 enrolled 44 charts

Carcinoma, Renal Cell

NCT03748901 2021-08-30

PD-L1 Expression in Japanese Renal Cell Carcinoma Patients

830 enrolled

Carcinoma, Renal Cell

NCT04680416 2021-08-25

Tissue Collection to ID TCRs From Renal Clear Cell Carcinoma Patients Responding to Immune Checkpoint Inhibitors

Carcinoma, Renal Cell

NCT04309617 2021-05-19

Retrospective Study on Referral Patterns for High Risk Patients Post Nephrectomy

618 enrolled 33 charts

Carcinoma, Renal Cell

NCT01401777 2021-04-27

Electromagnetic Tracking of Devices During Interventional Procedures - A Cryoablation Study

Carcinoma, Renal Cell

NCT02537743 2021-03-25

PROKidney

98 enrolled

Carcinoma, Renal Cell

NCT04637204 2021-02-01

Real-world Treatment Patterns and Outcomes Among aRCC Patients on Cabozantinib or Axitinib in England

1,540 enrolled

Carcinoma, Renal Cell

NCT04609800 2020-12-21

CAROLINE